Go to deals
Healthcare | Private Equity

Avicenna Holdings Limited has been acquired by Juno Health

The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.

Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.

Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.

Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”

Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.

Parties

Talk to the deal team

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Rebecca McCredie

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more